Literature DB >> 18302806

Predicting mortality with pneumonia severity scores: importance of model recalibration to local settings.

P Schuetz1, M Koller, M Christ-Crain, E Steyerberg, D Stolz, C Müller, H C Bucher, R Bingisser, M Tamm, B Müller.   

Abstract

In patients with community-acquired pneumonia (CAP) prediction rules based on individual predicted mortalities are frequently used to support decision-making for in-patient vs. outpatient management. We studied the accuracy and the need for recalibration of three risk prediction scores in a tertiary-care University hospital emergency-department setting in Switzerland. We pooled data from patients with CAP enrolled in two randomized controlled trials. We compared expected mortality from the original pneumonia severity index (PSI), CURB65 and CRB65 scores against observed mortality (calibration) and recalibrated the scores by fitting the intercept alpha and the calibration slope beta from our calibration model. Each of the original models underestimated the observed 30-day mortality of 11%, in 371 patients admitted to the emergency department with CAP (8.4%, 5.5% and 5.0% for the PSI, CURB65 and CRB65 scores, respectively). In particular, we observed a relevant mortality within the low risk classes of the original models (2.6%, 5.3%, and 3.7% for PSI classes I-III, CURB65 classes 0-1, and CRB65 class 0, respectively). Recalibration of the original risk models corrected the miscalibration. After recalibration, however, only PSI class I was sensitive enough to identify patients with a low risk (i.e. <1%) for mortality suitable for outpatient management. In our tertiary-care setting with mostly referred in-patients, CAP risk scores substantially underestimated observed mortalities misclassifying patients with relevant risks of death suitable for outpatient management. Prior to the implementation of CAP risk scores in the clinical setting, the need for recalibration and the accuracy of low-risk re-classification should be studied in order to adhere with discharge guidelines and guarantee patients' safety.

Entities:  

Mesh:

Year:  2008        PMID: 18302806      PMCID: PMC2870789          DOI: 10.1017/S0950268808000435

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  24 in total

1.  Substantial effective sample sizes were required for external validation studies of predictive logistic regression models.

Authors:  Yvonne Vergouwe; Ewout W Steyerberg; Marinus J C Eijkemans; J Dik F Habbema
Journal:  J Clin Epidemiol       Date:  2005-05       Impact factor: 6.437

2.  Evaluating physicians' probabilistic judgments.

Authors:  R M Poses; R D Cebul; R M Centor
Journal:  Med Decis Making       Date:  1988 Oct-Dec       Impact factor: 2.583

3.  Validation of the pneumonia severity index. Importance of study-specific recalibration.

Authors:  W D Flanders; G Tucker; A Krishnadasan; D Martin; E Honig; W M McClellan
Journal:  J Gen Intern Med       Date:  1999-06       Impact factor: 5.128

4.  Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia.

Authors:  Drahomir Aujesky; Thomas E Auble; Donald M Yealy; Roslyn A Stone; D Scott Obrosky; Thomas P Meehan; Louis G Graff; Jonathan M Fine; Michael J Fine
Journal:  Am J Med       Date:  2005-04       Impact factor: 4.965

5.  A prediction rule to identify low-risk patients with community-acquired pneumonia.

Authors:  M J Fine; T E Auble; D M Yealy; B H Hanusa; L A Weissfeld; D E Singer; C M Coley; T J Marrie; W N Kapoor
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

6.  Assessing the generalizability of prognostic information.

Authors:  A C Justice; K E Covinsky; J A Berlin
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

7.  Community acquired pneumonia: aetiology and usefulness of severity criteria on admission.

Authors:  A M Neill; I R Martin; R Weir; R Anderson; A Chereshsky; M J Epton; R Jackson; M Schousboe; C Frampton; S Hutton; S T Chambers; G I Town
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

8.  Validation of a predictive rule for the management of community-acquired pneumonia.

Authors:  A Capelastegui; P P España; J M Quintana; I Areitio; I Gorordo; M Egurrola; A Bilbao
Journal:  Eur Respir J       Date:  2006-01       Impact factor: 16.671

9.  A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia.

Authors:  K L Buising; K A Thursky; J F Black; L MacGregor; A C Street; M P Kennedy; G V Brown
Journal:  Thorax       Date:  2006-01-31       Impact factor: 9.139

10.  Economic costs of respiratory tract infections in the United States.

Authors:  R E Dixon
Journal:  Am J Med       Date:  1985-06-28       Impact factor: 4.965

View more
  26 in total

1.  Reorganising the pandemic triage processes to ethically maximise individuals' best interests.

Authors:  Andrew Tillyard
Journal:  Intensive Care Med       Date:  2010-08-06       Impact factor: 17.440

Review 2.  Validity of British Thoracic Society guidance (the CRB-65 rule) for predicting the severity of pneumonia in general practice: systematic review and meta-analysis.

Authors:  Maggie McNally; James Curtain; Kirsty K O'Brien; Borislav D Dimitrov; Tom Fahey
Journal:  Br J Gen Pract       Date:  2010-10       Impact factor: 5.386

3.  The Next Generation of Clinical Decision Making Tools: Development of a Real-Time Prediction Tool for Outcome of Prostate Biopsy in Response to a Continuously Evolving Prostate Cancer Landscape.

Authors:  Andreas N Strobl; Ian M Thompson; Andrew J Vickers; Donna P Ankerst
Journal:  J Urol       Date:  2015-01-28       Impact factor: 7.450

4.  CURB-65 score predicted mortality in community-acquired pneumonia better than IDSA/ATS minor criteria in a low-mortality-rate setting.

Authors:  Q Guo; H-Y Li; Y-P Zhou; M Li; X-K Chen; H Liu; H-L Peng; H-Q Yu; X Chen; N Liu; L-H Liang; Q-Z Zhao; M Jiang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-18       Impact factor: 3.267

5.  Prognostic factors for mortality due to pneumonia among adults from different age groups in Singapore and mortality predictions based on PSI and CURB-65.

Authors:  Zoe Xiaozhu Zhang; Yang Yong; Wan C Tan; Liang Shen; Han Seong Ng; Kok Yong Fong
Journal:  Singapore Med J       Date:  2017-08-14       Impact factor: 1.858

Review 6.  Predictors of treatment failure and clinical stability in patients with community acquired pneumonia.

Authors:  Deirdre Morley; Antoni Torres; Catia Cillóniz; Ignacio Martin-Loeches
Journal:  Ann Transl Med       Date:  2017-11

Review 7.  Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis.

Authors:  James D Chalmers; Pallavi Mandal; Aran Singanayagam; Ahsan R Akram; Gourab Choudhury; Philip M Short; Adam T Hill
Journal:  Intensive Care Med       Date:  2011-06-10       Impact factor: 17.440

8.  Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators.

Authors:  Andreas N Strobl; Andrew J Vickers; Ben Van Calster; Ewout Steyerberg; Robin J Leach; Ian M Thompson; Donna P Ankerst
Journal:  J Biomed Inform       Date:  2015-05-16       Impact factor: 6.317

Review 9.  Meta-analysis of Calibration, Discrimination, and Stratum-Specific Likelihood Ratios for the CRB-65 Score.

Authors:  Mark H Ebell; Mary E Walsh; Tom Fahey; Maggie Kearney; Christian Marchello
Journal:  J Gen Intern Med       Date:  2019-04-16       Impact factor: 5.128

Review 10.  Role of procalcitonin use in the management of sepsis.

Authors:  Claudia Gregoriano; Eva Heilmann; Alexandra Molitor; Philipp Schuetz
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.